Instil Bio, Inc. Common Stock
Symbol: TIL (NASDAQ)
24.00
▲ (0.84%) 0.200
Company Description:
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Key Stats
- Today's Open: $23.95
- Today's High: $24
- Today's Low: $23.95
- Today's Volume: 4.40K
- Yesterday Close: $23.8
- Yesterday High: $24.4918
- Yesterday Low: $23
- Yesterday Volume: 158.12K
- Last Min Volume: 1
- Last Min High: $24
- Last Min Low: $24
- Last Min VWAP: $24
Company Profile
- Name: Instil Bio, Inc. Common Stock
- Website: https://www.instilbio.com
- Listed Date: 2021-03-19
- Location: DALLAS, TX
- Market Status: Active
- CIK Number: 0001789769
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $155.13M
- Round Lot: 100
- Outstanding Shares: 6.75M
- Asset Type: CS
RECENT FILINGS FOR TIL
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | 144 | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-13 | 8-K | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-07-31 | 8-K | View |
| 2025-05-29 | 4 | View |
| 2025-05-29 | 4 | View |
| 2025-05-29 | 4 | View |
| 2025-05-29 | 4 | View |
| 2025-05-28 | 8-K | View |
| 2025-05-27 | 8-K | View |
| 2025-05-22 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-13 | 10-Q | View |
| 2025-05-13 | 8-K | View |
| 2025-05-02 | DEFR14A | View |
| 2025-04-28 | 4 | View |
| 2025-04-28 | 4 | View |
| 2025-04-14 | ARS | View |
Latest News on TIL